1. Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose‐prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease. Issue 9 (4th July 2020) Authors: George, Alex; Dinu, Bogdan; Estrada, Norma; Minard, Charles G.; Hurwitz, Richard; Mahoney, Donald H.; Yates, Amber M.; Vaughan, Mary; Carmouche, Alaundra; Airewele, Gladstone; Kirk, Susan E.; Fasipe, Titilope; Uwaezuoke, Precious; Ware, Russell E. Journal: American journal of hematology Issue: Volume 95:Issue 9(2020:Sep.) Page Start: E242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PedsQL™ multidimensional fatigue scale in sickle cell disease: Feasibility, reliability, and validity. Issue 1 (13th September 2013) Authors: Panepinto, Julie A.; Torres, Sylvia; Bendo, Cristiane B.; McCavit, Timothy L.; Dinu, Bogdan; Sherman‐Bien, Sandra; Bemrich‐Stolz, Christy; Varni, James W. Journal: Pediatric blood & cancer Issue: Volume 61:Issue 1(2014:Jan.) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PedsQL™ sickle cell disease module: Feasibility, reliability, and validity1. Issue 8 (25th February 2013) Authors: Panepinto, Julie A.; Torres, Sylvia; Bendo, Cristiane B.; McCavit, Timothy L.; Dinu, Bogdan; Sherman‐Bien, Sandra; Bemrich‐Stolz, Christy; Varni, James W. Journal: Pediatric blood & cancer Issue: Volume 60:Issue 8(2013:Aug.) Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗